TMDX FY 2022 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

FY 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$93M+208.8% YoY

Gross Profit

$65M69.8% margin

Operating Income

-$31M-33.6% margin

Net Income

-$36M-38.8% margin

EPS (Diluted)

$-1.23

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$58M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$277M

Total Liabilities

$90M

Stockholders' Equity

$187M

Cash & Equivalents

$201M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$93M	$30M	+208.8%
Gross Profit	$65M	$21M	+208.5%
Operating Income	-$31M	-$39M	+20.3%
Net Income	-$36M	-$44M	+18.1%